ALLEGAN, Mich., Feb. 8 /PRNewswire-FirstCall/ -- The Perrigo Company
(Nasdaq: PRGO; TASE) today announced that the Board of Directors has
authorized the repurchase of $60 million of the Company's common stock
through February 8, 2009 under its ongoing share repurchase program. Any
remaining balance of the previously authorized program will expire on
February 17, 2007. Under share repurchase programs since November 2000,
Perrigo has repurchased 9.4 million shares at a cost of approximately $118
million. As of January 29, 2007, Perrigo had 92,589,609 common shares
outstanding.
The Company also announced that its Board of Directors declared a
quarterly dividend of $0.045 per share, payable on March 20, 2007 to
shareholders of record on February 23, 2007.
The Perrigo Company is a leading global healthcare supplier and the
world's largest manufacturer of over-the-counter (OTC) pharmaceutical and
nutritional products for the store brand market. Store brand products are
sold by food, drug, mass merchandise, dollar store and club store retailers
under their own labels. The Company also develops, manufactures and markets
prescription generic drugs, active pharmaceutical ingredients and consumer
products, and operates manufacturing facilities in the United States,
Israel, the United Kingdom, Mexico, Germany and China. Visit Perrigo on the
Internet (http://www.perrigo.com).
SOURCE Perrigo Company
 back to top
Related links:
http://www.perrigo.com
CONTACT:
Arthur J. Shannon, Vice President, Investor
Relations and Communication, +1-269-686-1709,
ajshannon@perrigo.com, or Ernest J. Schenk, Manager, Investor
Relations and Communication, +1-269-673-9212,
eschenk@perrigo.com, both of Perrigo Company
|
